Fig. 4
From: IL-10 and integrin signaling pathways are associated with head and neck cancer progression
Overall Survival Kaplan-Maier estimates for gene signature (PAGE4, SMTNL1, VTN, CA5A, C1orf43, KRTAP19-1, LEP, HRH4, PAGE5, SEZ6L, CREB3; Logrank Test P-Value: 0. 03443). Censored patients are indicated by tick marks. Signature is based on those genes differentially expressed and also mutated only in progressors. Red indicates cases with alterations in those genes (based on Z > 2.5) Median survival in months for those with alterations in the gene signature is 17.94 months compared to 108.88 months for those without the alterations